β2-Adrenoceptor confers cardioprotection against hypoxia in isolated ventricular myocytes and the effects depend on estrogenic environment

Journal of Receptors and Signal Transduction

Volumn 30, Issue 4, 2010, Pages 255-261

  Xu, Chuanying ^a   Liu, Aiying ^a   Sun, Hong ^a   Sun, Yiwei ^a   Wang, Guangming ^a   Gao, Liping ^a   Hao, Yanling ^a   Yan, Changdong ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

2 adrenoceptor; Cardioprotection; Contraction; Estrogen; Hypoxia reoxygenation; Myocyte

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; BETA 2 ADRENERGIC RECEPTOR; LACTATE DEHYDROGENASE; ESTROGEN; ISOPRENALINE; PROPANOLAMINE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL DEATH; CELL ISOLATION; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME RELEASE; ESTROGEN ACTIVITY; FEMALE; HEART MUSCLE INJURY; HEART PROTECTION; HYPOXIA; INCUBATION TIME; MUSCLE CELL; MUSCLE FIBER CONTRACTION; NONHUMAN; OVARIECTOMY; PROTEIN EXPRESSION; RAT; REOXYGENATION; ANIMAL; CELL HYPOXIA; CELL PROTECTION; CELL SEPARATION; CELL SURVIVAL; CYTOLOGY; DRUG EFFECT; HEART MUSCLE CELL; HEART VENTRICLE; METABOLISM; SPRAGUE DAWLEY RAT;

RATTUS;

ANIMALS; CELL HYPOXIA; CELL SEPARATION; CELL SURVIVAL; CYTOPROTECTION; ESTROGENS; FEMALE; HEART VENTRICLES; ISOPROTERENOL; MYOCYTES, CARDIAC; OVARIECTOMY; PROPANOLAMINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, BETA-2;

EID: 77954495244     PISSN: 10799893     EISSN: 15324281     Source Type: Journal    
DOI: 10.3109/10799893.2010.488242     Document Type: Article

References (28)

1. Xiao RP, Zhu W, Zheng M, et al. Subtype-specific-adrenoceptor signaling pathways in the heart and their potential clinical implications. Trends Pharmacol Sci 2004, 25, 358-365.
2. Chesley A, Lundberg MS, Asai T, et al. The beta(2)-adrenergic receptor delivers an antiapoptotic signal to cardiac myocytes through G(i)-dependent coupling to phosphatidylinositol 3'-kinase. Circ Res 2000, 87, 1172-1179.
3. Zheng M, Zhu W, Han Q, et al. Emerging concepts and therapeutic implications of beta-adrenergic receptor subtype signaling. Pharmacol Ther 2005, 108, 257-268.
4. Zhu W, Zeng X, Zheng M, et al. The enigma of beta2-adrenergic receptor Gi signaling in the heart: the good, the bad, and the ugly. Circ Res. 2005, 97, 507-509.
5. Xiao RP, Zhu W, Zheng M, et al. Subtype-specific alpha1- and beta-adrenoceptor signaling in the heart. Trends Pharmacol Sci 2006, 27, 330-337.
6. Persad S, Panagia V, Dhalla NS. Role of H2O2 in changing betaadrenoceptor and adenylyl cyclase in ischemia-reperfused hearts. Mol Cell Biochem 1998, 186, 99-106.
7. Wang X, Wang J, Takeda S, et al. Alterations of cardiac-adrenoceptor mechanisms due to calcium depletion and repletion. Mol Cell Biochem 2002, 232, 63-73.
8. Saini HK, Dhalla NS. Defective calcium handling in cardiomyocytes isolated from hearts subjected to ischemia-reperfusion. Am J Physiol Heart Circ Physiol 2005, 288, H2260-H2270.
9. Grodstein F, Stampfer M. The epidemiology of coronary heart disease and estrogen replacement in postmenopausal women. Prog Cardiovasc Dis 1995, 38, 199-210.
10. Hale SL, Birnbaum Y, Kloner RA. Estradiol, administered acutely, protects ischemic myocardium in both female and male rabbits. J Cardiovasc Pharmacol Ther 1997, 2, 47-52.
11. Murphy E, Steenbergen C. Cardioprotection in females: a role for nitric oxide and altered gene expression. Heart Fail Rev 2007, 12, 293-300.
12. Sullivan JM, Vander Zwaag R, Lemp GF, et al. Postmenopausal estrogen use and coronary atherosclerosis. Ann Intern Med 1988, 108, 358-363.
13. Wu Q, Zhao Z, Sun H, et al. Estrogen changed cardiomyocyte contraction and beta-adrenoceptor expression in rat hearts subjected to ischaemia- reperfusion. Exp Physiol 2008, 93, 1034-1043.
14. Patten RD, Pourati I, Aronovitz MJ, et al. 17Beta-estradiol reduces cardiomyocyte apoptosis in vivo and in vitro via activation of phospho-inositide-3 kinase/Akt signaling. Circ Res 2004, 95, 692-699.
15. Tune JD, Gorman MW, Feigl EO. Matching coronary blood flow to myocardial oxygen consumption. J Appl Physiol 2004, 97, 404-415.
16. Nayler WG, Poole-Wilson PA, Williams A. Hypoxia and calcium. J Mol Cell Cardiol 1979, 11, 683-706.
17. Camici PG. Hibernation and heart failure. Heart 2004, 90, 141-143.
18. Sun H, Zhou F, Wang Y, et al. Effects of beta-adrenoceptors overexpression on cell survival are mediated by Bax/Bcl-2 pathway in rat cardiac myocytes. Pharmacology 2006, 78, 98-104.
19. Hao Y, Sun Y, Xu C, et al. Improvement of contractile function in isolated cardiomyocytes from ischemia-reperfusion rats by ginkgolide B pretreatment. J Cardiovasc Pharmacol 2009, 54, 3-9.
20. Alekseev AE, Markevich NI, Korystova AF, et al. Comparative analysis of the kinetic characteristics of L-type calcium channels in cardiac cells of hibernators. Biophys J 1996, 70, 786-797.
21. Gong H, Adamson DL, Ranu HK, et al. The effect of Gi-protein inactivation on basal, and 1- and 2AR-stimulated contraction of myocytes from transgenic mice overexpressing the 2-adrenoceptor. Br J Pharmacol 2000, 131, 594-600.
22. Harding SE, Vescovo G, Kirby M, et al. Contractile responses of isolated adult rat and rabbit cardiac myocytes to isoproterenol and calcium. J Mol Cell Cardiol 1988, 20, 635-647.
23. Zhou JJ, Pei JM, Wang GY, et al. Inducible HSP70 mediates delayed cardioprotection via U-50488H pretreatment in rat ventricular myocytes. Am J Physiol Heart Circ Physiol 2001, 281, H40-H47.
24. Penson PE, Ford WR, Kidd EJ, et al. Activation of beta- adrenoceptors mimics preconditioning of rat-isolated atria and ventricles against ischaemic contractile dysfunction. Naunyn Schmiedebergs Arch Pharmacol 2004, 378, 589-597.
25. Penna C, Abbadessa G, Mancardi D, et al. Synergistic effects against post-ischemic cardiac dysfunction by sub-chronic nandrolone pretreatment and postconditioning: role of beta2- adrenoceptor. J Physiol Pharmacol 2005, 59, 645-659.
26. Camici PG, Prasad SK, Rimoldi OE. Stunning, hibernation, and assessment of myocardial viability. Circulation 2008, 117, 103-114.
27. Stumpe T, Schrader J. Short-term hibernation in adult cardiomyocytes is PO2 dependent and Ca2+ mediated. Am J Physiol Heart Circ Physiol 2001, 49, H42-H50.
28. Murphy E, Steenbergen C. Gender-based differences in mechanisms of protection in myocardial ischemia-reperfusion injury. Cardiovasc Res 2007, 75, 478-486.